Post-Grant Review Of Antibody-Drug Conjugate Patent Requested
ALEXANDRIA, Va. — Two pharmaceutical companies on Jan. 22 petitioned the Patent Trial and Appeal Board for post-grant review (PGR) of a recently issued patent relating to cancer therapy....To view the full article, register now.
Already a subscriber? Click here to view full article